Raghu Rao
Internal Medicine · Newberry, MINPI 1720148307
Payments from drug & device makers
Across 131 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$507
- Novo Nordisk$202
- Boehringer Ingelheim$192
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$141
- Amgen$128
- Pfizer$124
- plus $846 from 15 others
What the payments were for
- Food & beverage$2,140100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $507 |
| Novo Nordisk | 13 | $202 |
| Boehringer Ingelheim | 9 | $192 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $141 |
| Amgen(2 entities) | 7 | $128 |
| Pfizer | 9 | $124 |
| Bayer | 7 | $118 |
| AstraZeneca | 8 | $118 |
| Lilly USA, LLC | 6 | $94 |
| GSK | 6 | $89 |
| Johnson & Johnson | 6 | $85 |
| Novartis | 7 | $80 |
| Merck | 5 | $73 |
| Indivior Inc. | 2 | $47 |
| Dexcom, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Exact Sciences | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,140 in reported general payments places this provider in the 80th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 166 | $110,790 |
| RybelsusSemaglutide | 66 | $76,658 |
| JanuviaSitagliptin Phosphate | 118 | $62,107 |
| XareltoRivaroxaban | 58 | $50,270 |
| TrulicityDulaglutide | 46 | $43,993 |
| LinzessLinaclotide | 57 | $33,682 |
| JardianceEmpagliflozin | 42 | $31,424 |
| OzempicSemaglutide | 33 | $31,012 |
| EntrestoSacubitril/Valsartan | 49 | $24,554 |
| VraylarCariprazine Hcl | 24 | $19,825 |
| MyrbetriqMirabegron | 43 | $19,312 |
| MounjaroTirzepatide | 15 | $16,675 |
| FarxigaDapagliflozin Propanediol | 26 | $15,615 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $14,136 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,710 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $124 | $110,790166 claims |
| Novo NordiskRybelsus, Ozempic | $202 | $107,66999 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $94 | $63,41872 claims |
| MerckJanuvia | $73 | $62,107118 claims |
| AbbVieLinzess, Vraylar | $507 | $53,50781 claims |
| Johnson & JohnsonXarelto | $85 | $50,27058 claims |
| Boehringer IngelheimJardiance | $192 | $31,42442 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $89 | $26,84743 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $118 | $24,82440 claims |
| NovartisEntresto | $80 | $24,55449 claims |
| Astellas Pharma US IncMyrbetriq | $15 | $19,31243 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Newberry
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.